SMC restricts use of buprenorphine (Buvidal®) for treatment of opioid dependence

Source:
Scottish Medicines Consortium - SMC
Publisher:
Scottish Medicines Consortium
Publication date:
12 August 2019

Abstract

The SMC has restricted use to patients in whom methadone is not suitable and for whom the use of buprenorphine is considered appropriate.